Pages that link to "Q41608409"
Jump to navigation
Jump to search
The following pages link to Modulation of cell-surface transferrin receptor by the imino sugar N-butyldeoxynojirimycin. (Q41608409):
Displaying 11 items.
- Substrate reduction therapy for glycosphingolipid storage disorders (Q32066333) (← links)
- Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease (Q33348492) (← links)
- Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy (Q34281044) (← links)
- Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells (Q34334511) (← links)
- Targeting glycosylation as a therapeutic approach (Q34741569) (← links)
- Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin (Q35101574) (← links)
- N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure (Q35870903) (← links)
- Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases (Q36227994) (← links)
- Role of Glycan Processing in Hepatitis B Virus Envelope Protein Trafficking (Q41719365) (← links)
- In Planta Preliminary Screening of ER Glycoprotein Folding Quality Control (ERQC) Modulators (Q58038916) (← links)
- Inhibition ofN-Glycan Processing in B16 Melanoma Cells Results in Inactivation of Tyrosinase but Does Not Prevent Its Transport to the Melanosome (Q62403749) (← links)